Beijing Ql Biopharmaceutical Co.,ltd

This early-stage trial tested the safety and tolerability of ZT002, an injectable drug for weight loss, in 28 adults with overweight or obesity. Participants received multiple doses of ZT002 or a placebo to see how the body processes the drug and if any side effects occur. The st…

This early-stage trial tested ZT006, an experimental daily pill for weight loss, in 94 healthy, overweight, and obese adults. The study checked safety, how the body processes the drug, and the effect of food on absorption. Participants received single or multiple doses, with some…

This study tested an experimental injection called ZT002 in 303 adults who were overweight or obese. Participants received either the drug or a placebo for 24 weeks. The main goal was to see how much weight they lost and whether they achieved 5%, 10%, or 15% weight loss. The tria…